West Michigan Cancer Center & Institute for Blood Disorders (WMCC), a collaboration of Borgess / Ascension and Bronson Healthcare Group, is pleased to announce the addition of three providers.
Casey Hay, MD is a gynecologic oncologist with 7 years’ experience in clinical medicine. Dr. Hay earned her medical degree from the Michigan State University College of Human Medicine in East Lansing and completed her residency in obstetrics and gynecology at Maine Medical Center in Portland, Maine. Following her residency, she completed a fellowship in gynecologic oncology at Magee-Womens Hospital of UPMC in Pittsburgh, Pennsylvania. Dr. Hay is board eligible in obstetrics and gynecology and gynecologic oncology. Her clinical focus is minimally invasive surgery and comprehensive care for women with gynecologic malignancies including cancer of the ovaries, uterus, cervix, fallopian tubes, vulva and vagina.
Iman Mohamed, MD MPH is a medical oncologist with 33 years’ experience in clinical medicine. Dr. Mohamed earned her medical degree at Kuwait University in Kuwait City, Kuwait and a Master of Public Health degree through Northwest Ohio Consortium of Public Health Programs with a focus on health education. After obtaining specialty training at the Royal College of Physicians in London (UK), she completed residency at St. Joseph Mercy Hospital in Pontiac and a fellowship in medical oncology at William Beaumont Hospital in Royal Oak. Dr. Mohamed is board certified in internal medicine and medical oncology. Her clinical focus is breast cancer of all stages in addition to offering consultations in cancer genetics and risk reduction.
Muhammad Usman, MD is a hematologist and medical oncologist with 7 years’ experience in clinical medicine. Dr. Usman earned his medical degree at Baqai Medical University in Karachi, Pakistan. He completed his residency at Detroit Medical Center through the Wayne State University School of Medicine and a fellowship in hematology and oncology at Karmanos Cancer Institute in Detroit. Dr. Usman is board certified in internal medicine and board eligible in hematology and medical oncology. His clinical focus is benign hematology, hematologic malignancies including lymphoma, leukemia, myeloma and general oncology.